Ghost Tree Capital »

Acumen Pharmaceuticals shares owned by Ghost Tree Capital

Quarter-by-quarter ownership of Acumen Pharmaceuticals (ABOS) shares owned by Ghost Tree Capital from 13F filings

Historical chart of Ghost Tree Capital investment in Acumen Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Acumen Pharmaceuticals held by Ghost Tree Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acumen Pharmaceuticals by Ghost Tree Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $623k 150k 4.15

More positions owned by Ghost Tree Capital

Moonlake Immunotherapeutics Class A Ord (MLTX)
Sarepta Therapeutics (SRPT)
Spdr Ser Tr S&p Biotech Call Option (XBI)
Akero Therapeutics (AKRO)
Krystal Biotech (KRYS)
Madrigal Pharmaceuticals (MDGL)
Tg Therapeutics (TGTX)
Immunovant (IMVT)
Ascendis Pharma A/s Sponsored Adr (ASND)
Axsome Therapeutics (AXSM)
Alpine Immune Sciences (ALPN)
Syndax Pharmaceuticals (SNDX)
Vaxcyte (PCVX)
Tarsus Pharmaceuticals (TARS)
Apellis Pharmaceuticals Call Option (APLS)

View all positions for Ghost Tree Capital

Top funds holding Acumen Pharmaceuticals

RA Capital Management
Franklin Resources
Laurion Capital Management
Vanguard Group
Millennium Management
Alyeska Investment Group
Jane Street
Hudson Bay Capital Management
Schonfeld Strategic Advisors
Pathstone Holdings
Ikarian Capital
Tang Capital Management
Two Sigma Investments
Citigroup
Man Group

View all funds holding Acumen Pharmaceuticals